Tag : HKUA-HASUO CONSENSUS

  • RESEARCH SPOTLIGHT
    INDUSTRY ESSENTIALS

    Navigating genetic testing in prostate cancer: An insight into the joint HKUA-HKSUO consensus recommendations

    In 2019, prostate cancer (PC) was ranked the third most frequently diagnosed cancer among men in Hong Kong. Though genetic testing has not been previously considered a routine approach of PC patient care, recent sequencing studies revealed that about 11.8% of metastatic PC (mPC) patients carried in

    doctor name

    Front Oncol. 2022.

    Chiu PKF, Lee EKC, Chan MTY, Chan WHC, Cheung MH, Lam MHC, Ma ESK, Poon DMC. Genetic testing and its clinical application in prostate cancer management: Consensus statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology. Front Oncol. 2022;12:962958.